Company Immunotech Biopharm Ltd

Equities

6978

KYG4721A1004

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Hong Kong S.E. Other stock markets 01:39:00 03/05/2024 pm IST			5-day change	1st Jan Change
3.43 ^HKD	+0.88%		+1.78%	-31.40%

29/03	Immunotech Biopharm Posts Nearly 335 Million Yuan Loss in 2023	MT
28/03	Immunotech Biopharm Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.

Number of employees: 211

Managers	Title	Age	Since
Yu Wang CEO	Chief Executive Officer	57	23/19/23
Ning Yang DFI	Director of Finance/CFO	43	01/19/01
Yu Zhang CTO	Chief Tech/Sci/R&D Officer	60	24/18/24
Jian Zhang SAM	Sales & Marketing	53	05/18/05

Members of the board	Title	Age	Since
Rui Hua Wang BRD	Director/Board Member	60	24/23/24
Ying Dian Wang BRD	Director/Board Member	63	01/19/01
Ran Tao BRD	Director/Board Member	59	23/21/23
Chi Kit Ng BRD	Director/Board Member	51	01/20/01
Zheng Tan CHM	Chairman	46	01/18/01
Yu Wang CEO	Chief Executive Officer	57	23/19/23
Su Jiu Peng BRD	Director/Board Member	44	01/19/01
Fan Yang BRD	Director/Board Member	43	24/23/24
Dong Hu Wang BRD	Director/Board Member	69	25/23/25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	514,584,000	228,862,314 ( 44.48 %)	0	44.48 %

Name	Equities	%	Valuation
Zheng Tan 36.04 %	185,480,000	36.04 %	88 M $
TASLY PHARMACEUTICAL GROUP CO., LTD 18.87 %	97,102,571	18.87 %	46 M $
Hyun Chul Jung 8.710 %	44,820,000	8.710 %	21 M $
Bosera Asset Management Co., Ltd. 0.1947 %	1,002,000	0.1947 %	477 543 $
China Asset Management (Hong Kong) Ltd. 0.001360 %	7,000	0.001360 %	3 336 $

Immunotech Biopharm Ltd.

Guosheng Technology Park No.1 Kangding Street

, Beijing

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
IMMUNOTECH BIOPHARM LTD	-31.40%	224M
VERTEX PHARMACEUTICALS INCORPORATED	-1.43%	103B
REGENERON PHARMACEUTICALS, INC.	+8.96%	101B
ARGENX SE	+4.40%	23.07B
BIONTECH SE	-12.15%	22.23B
GENMAB A/S	-4.36%	18.05B
WUXI APPTEC CO., LTD.	-39.98%	17.18B
BEIGENE, LTD.	-10.04%	16.94B
NEUROCRINE BIOSCIENCES, INC.	+6.79%	14.07B
SAREPTA THERAPEUTICS, INC.	+38.61%	12.35B

Bio Therapeutic Drugs